Skip to main content
. 2020 Mar 6;9(6):674–685. doi: 10.1002/sctm.19-0338

Figure 4.

Figure 4

Diagram showing the principal steps in a clinical trial using autologous as compared to allogenic HSPCs. HPSCs were harvested from patients and healthy donors and cultivated in vitro. Once an optimal number of cells with the appropriate phenotype were obtained, they were subjected to gene editing and then infused back into the patient who was treated with the appropriate conditioning regimen